Overview

Valsartan/Amlodipine As Compared to Losartan Treatment in Stage 2 Systolic Hypertension

Status:
Completed
Trial end date:
2010-01-01
Target enrollment:
Participant gender:
Summary
This study will compare the antihypertensive efficacy and safety of a valsartan/amlodipine-based treatment with a losartan-based treatment in patients with Stage 2 systolic hypertension (high blood pressure, mean systolic blood pressure greater than 160 and less than 200 mmHg).
Phase:
Phase 4
Details
Lead Sponsor:
Novartis
Treatments:
Amlodipine
Hydrochlorothiazide
Losartan
Valsartan